Low frequency of the V106M mutation among HIV-1 subtype C-infected pregnant women exposed to nevirapine

AIDS

Volumn 17, Issue 11, 2003, Pages 1698-1700

  Morris, Lynn ^a   Pillay, Candice ^a   Chezzi, Claudia ^a   Lupondwana, Pumla ^b   Ntsala, Matshediso ^a   Levin, Leon ^d   Venter, Francois ^b   Martinson, Neil ^b,c   Gray, Glenda ^b   McIntyre, James ^b  

^a NATIONAL INSTITUTE FOR COMMUNICABLE DISEASES   (South Africa)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

EFAVIRENZ; NEVIRAPINE;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRENATAL EXPOSURE; PRIORITY JOURNAL; SINGLE DRUG DOSE; VERTICAL TRANSMISSION; VIRUS MUTATION; VIRUS STRAIN;

ADULT; DEVELOPING COUNTRIES; DISEASE TRANSMISSION, VERTICAL; DRUG RESISTANCE, VIRAL; FEMALE; GENE FREQUENCY; HIV INFECTIONS; HIV-1; HUMANS; INFANT, NEWBORN; NEVIRAPINE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; REVERSE TRANSCRIPTASE INHIBITORS; SOUTH AFRICA;

EID: 0041626276     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200307250-00017     Document Type: Article

References (3)

1. Brenner B, Turner D, Oliveira M, Moisi D, Detorio M, Carobene M, et al. A V106M mutation in HIV-1 clade C viruses exposed to efavirenz confers cross-resistance to non-nucleoside reverse transcriptase inhibitors. AIDS 2003; 17:F1-F5.
2. Pillay C, Bredell H, McIntyre J, Gray G, Morris L. HIV-1 subtype C reverse transcriptase sequences from drug-naive pregnant women in South Africa. AIDS Res Hum Retroviruses 2002; 18:605-610.
3. Eshleman SH, Mracna M, Guay LA, Deseyve M, Cunningham S, Mirochnick M, et al. Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012). AIDS 2001; 15:1951-1957.